Skip to main content

Table 7 Comparison of average terminal tumor volumes of GemHCl and 4NSG-SLN treated mice bearing PCa tumors obtained from Black and White pancreatic cancer patients

From: Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

Day

Mean terminal tumor volume (mm3)

GemHClBT

GemHClWT

p-valueǂ

4NSG-SLNBT

4NSG-SLNWT

p-value¤

0

0

0

Ns

0

0

0

1

12.5 ± 6

13.9 ± 2

ns

12.6 ± 2

16 ± 3

0.004

3

25.0 ± 12

27.8 ± 4

ns

25.3 ± 3

32 ± 5

0.004

5

35.7 ± 18

39.7 ± 5

ns

36.2 ± 4

46.1 ± 9

0.004

7

73.0 ± 21

43.5 ± 16

ns

51.2 ± 9

50.7 ± 17

ns

9

229. ± 181

177.8 ± 60

ns

129 ± 35

182 ± 44

0.03

11

662. ± 198

583.2 ± 227

ns

341.4 ± 166

247.8 ± 76

ns

13

767. ± 194

646.9 ± 240

ns

375.6 ± 182

300 ± 90

ns

15

911. ± 152

752.6 ± 241

ns

418 ± 196

359.4 ± 108

ns

17

990. ± 151

850.8 ± 205

ns

449 ± 226

421 ± 112

ns

19

1129 ± 172

868.2 ± 294

ns

432 ± 105

494.8 ± 121

ns

21

1204 ± 184

1053 ± 86

0.05

429.3 ± 68

564.5 ± 128

ns

23

1456 ± 154

1344.7 ± 171

ns

521.7 ± 71

896.3 ± 93

0.0003

25

1681 ± 172

1748.2 ± 223

ns

1044.5 ± 40

1002.7 ± 96

ns

  1. Data expressed in mean ± SD, n = 5